Detalhe da pesquisa
1.
A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B.
J Hepatol
; 78(5): 926-936, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062574
2.
Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry.
Z Gastroenterol
; 61(1): 60-70, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623544
3.
miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
J Pathol
; 252(3): 239-251, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32710569
4.
HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis.
BMC Cancer
; 19(1): 1191, 2019 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31805897
5.
Evolution of HCV patient characteristics and DAA regimens in the German Hepatitis C Registry (DHC-R) in 2014 and 2015.
Z Gastroenterol
; 57(5): 584-592, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31083746
6.
DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
Histopathology
; 70(7): 1064-1071, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28130841
7.
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinoma.
Virchows Arch
; 476(6): 871-880, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838585